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PDGFCaveolae and caveolin have been implicated as being involved in the signal transduction of many receptors,
including the EGF, PDGF, LPA and β3-adrenergic receptors. To investigate the role of caveolin-1 (Cav1) in
these signaling pathways in brown adipose tissue, primary brown adipocyte cultures from Cav1-ablated
mice and wild-type mice were investigated. In pre-adipocytes, Cav1-ablation affected neither the G-protein
coupled LPA receptor signaling to Erk1/2, nor the receptor tyrosine kinases PDGF- or EGF-receptor signaling
to Erk1/2. Mature primary Cav1(−/−) brown adipocytes accumulated lipids and expressed aP2 to the same
extent as did wild-type cells. However, the cAMP levels induced by the β3-adrenergic receptor agonist
CL316,243 were lower in the Cav1(−/−) cultures, with an unchanged EC50 for CL316,243. Also the response
to the direct adenylyl cyclase agonist forskolin was reduced. Thus, in brown adipocytes, Cav1 is apparently
required for an intact response to adenylyl cyclase-linked agonists/activators, whereas other signaling
pathways examined function without Cav1.6 8 156756.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Caveolae are 50–100 nm invaginations in the plasma membrane
that can serve as signaling platforms. They have a high abundance of
sphingolipids and cholesterol, and also contain the caveolin proteins:
caveolin-1, -2 and -3 (Cav1, 2, 3). Caveolae are present in most cell
types, but are highly enriched in e.g. endothelial cells, myocytes, and
adipocytes. The caveolin proteins are differentially expressed, with
Cav1 and Cav2 being expressed in most cell types and Cav3 only
expressed in muscle tissue [1,2].
Several studies have investigated the importance of Cav1 and
caveolae for proper signal transduction in cells [1–6]. With the
generation of Cav1-ablated mice [7–10], the role of Cav1 in adipose
tissue function has been further studied. The Cav1-ablated mice have
impaired lipolysis in white adipocytes [11]. In brown adipose tissue,
Cav1-ablated mice subjected to fasting and cold for 24 h did not reduce
their triglyceride content asmuch as did thewild-type animals and they
were not able to maintain their body temperature [12]. However, on
prolonged exposure to cold, the Cav1-ablatedmicewere able to survive
through nonshivering thermogenesis, although they had desensitized
adrenergic receptor function and expressed less β3-adrenergic receptor
protein in brown adipose tissue [13]. Thus, although the Cav1-ablated
mice survived in prolonged cold, the β3-adrenergic receptor signaling
was impaired.In brown pre-adipocytes, both epidermal growth factor (EGF) and
platelet-derived growth factor (PDGF) can activate cell proliferation
via Erk1/2 phosphorylation [14]. Lysophosphatidic acid (LPA) also
activates Erk1/2 phosphorylation [15], and decreases PPARγ mRNA
expression in both white adipose tissue [16] and brown adipose tissue
(unpublished).
Cav1/caveolae and lipid rafts have been shown to different extents
to affect the signaling pathways of β3-adrenergic, LPA, PDGF and EGF
receptors [2,3,6,11,13,17–19]. However, the effect of Cav1-ablation on
such signaling pathways has not been studied in primary brown
adipocytes. In view of the signiﬁcance of these pathways for cell
proliferation, we have here examined the role of Cav1 in brown
adipocyte function. Wild-type and Cav1(−/−) primary brown
adipocyte cultures were grown and the signaling of β3-adrenergic,
LPA, PDGF and EGF receptors were investigated.
We found that Cav1(−/−) primary brown adipocyte cultures
were able to store lipids and were not morphologically different from
wild-type cultures. Activation of β3-adrenergic receptors or directly of
adenylyl cyclase resulted in a lower cAMP response in Cav1(−/−)
brown adipocytes than in wild-type; however LPA-, PDGF- and EGF-
induced Erk1/2 activation were not changed.
2. Materials and methods
2.1. Cell culture of brown adipocytes
The study was approved by the Animal Ethics Committee of the
North Stockholm region. Caveolin-1-ablated animals were purchased
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back-crossed to the C57Bl/6 strain for at least 7 generations. Wild-type
mice were on occasion purchased (B&K, Stockholm, Sweden). The mice
were kept at 22 °C with free access to food (andwater). At 3–4 week of
age, the mice were sacriﬁced by CO2 anaesthesia and cervical
dislocation. Primary brown adipocytes were prepared from pooled
interscapular, axillary and cervical brown adipose tissue depots,
principally as described earlier [14,20]. The cells were seeded onto
either 12 or 24-well plates (6 mice/plate) or microscope slides (BD
Biosciences) and cultured in DMEM supplemented with 10% newborn
calf serum (Gibco), 2.4 nM insulin (Novo Nordisk), 10 mM Hepes
(Gibco), 50 IU/ml penicillin (Gibco), 50 μg/ml streptomycin (Gibco),
25 μg/ml sodium ascorbate (Gibco) and 4 mM L-glutamine (Gibco) at
37 °C in an atmosphere of 8% CO2 in air. On day 1 in culture, cells were
washed with DMEM, and mediumwas added. Thereafter, medium was
changed every second day.
2.2. Microscopy
Primary brown adipocytes were grown in culture on microscope
slides for 8 days. The medium was discarded and the cells were ﬁxed
with 4% paraformaldehyde (PFA) for 15 min. Five percent glycine was
added to the cells for 5 min. The cells were then blocked for 1 h with
5% bovine serum albumin in PBS. To detect Cav1, primary Cav1
antibody (1:1000, BD Biosciences) was added overnight, slides were
then washed 3 times in PBS, and then incubated in secondary anti-
rabbit-Cy3 (1:500, Molecular Probes) for 1 h. To detect lipid droplets,
bodipy solution (Molecular Probes) was added for 1 h at the same
time as the secondary antibody. Hoechst solution (1 μg/ml) was
added for 10 min for staining of the nuclei. Slides were washed 3
times in PBS before mounting with ProLong Gold Antifade (Invitro-
gen). Images of cells were acquired on a confocal microscope (Zeiss
LSM 510 META Confocal Microscope).
2.3. Immunoblotting
To examine the level of Erk1/2 phosphorylation, cells were
serum-starved on either day 4 (pre-adipocytes) or day 7 (mature
adipocytes) with serum-free medium (DMEM/Ham's F12 (Gibco)
supplemented with 0.5% (w/v) fatty-acid free bovine serum
albumin (fraction V, Roche), 2.4 nM insulin, 10 mM Hepes, 50 IU/
ml penicillin, 50 μg/ml streptomycin, 25 μg/ml sodium ascorbate
and 4 mM L-glutamine). The next day, cells were treated as
indicated, medium was aspirated and cells were lysed directly in
the wells by addition of 30 μl SDS sample buffer (62.5 mM Tris–HCl
(pH 6.8), 10% glycerol, 2% SDS, 50 mM dithiothreitol and 0.1%
bromphenol blue), pre-warmed to 65 °C.
To examine aP2 (FABP4) protein amount, cells on day 8 were
lysed directly in the wells by addition of 30 μl SDS sample buffer
pre-warmed to 65 °C.
For all experiments, the cells were scraped off the wells and
transferred to microcentrifuge tubes on ice, followed by sonication for
5 sec per sample and heating to 100 °C for 5 min. The samples were
run on a 12% polyacrylamide gel and electrotransferred to a PVDF
membrane (GE Healthcare) with a semidry electroblotter. Primary
antibodies against phospho-Erk1/2 (p-Erk (Thr202/Tyr204); rabbit
polyclonal, Cell Signaling), total Erk1/2 (t-Erk; rabbit polyclonal, Cell
Signaling), aP2 (FABP4, rabbit polyclonal, Cell Signaling) and caveolin-
1 (Cav1; rabbit polyclonal, BD Biosciences) were used. The primary
antibodies were detected with a secondary antibody coupled to HRP
(anti-rabbit-HRP, Cell Signaling) and ECL (GE Healthcare, for Cav1) or
ECL Plus (GE Healthcare, for p-Erk, t-Erk, aP2). The blots were
quantiﬁed with a CCD-camera (LAS-1000, Fujiﬁlm) and ImageGauge.
To determine the level of Erk1/2 phosphorylation, the ratio
between phosphorylated and total Erk1/2 protein was calculated,
and the results were normalized to the highest agonist concentrationused. To conﬁrm equal loading for aP2, total Erk1/2 protein was also
measured on these membranes. No differences could be seen in the
amount of total Erk1/2 protein between wild-type and Cav1(−/−)
brown adipocyte cultures.
2.4. cAMP assay
On day 4 in culture, cells were serum-starved overnight in serum-
free medium (DMEM/Ham's F12 (Gibco) supplemented with 0.5%
(w/v) bovine serum albumin (Sigma), 2.4 nM insulin, 10 mM Hepes,
50 IU/ml penicillin, 50 μg/ml streptomycin, 25 μg/ml sodium ascor-
bate and 4 mM L-glutamine). On the next day, medium was changed
to experimental medium (DMEM/Ham's F12 (Gibco) supplemented
with 0.5% (w/v) bovine serum albumin (Sigma-Aldrich), 25 μg/ml
sodium ascorbate (Gibco), 4 mM L-glutamine (Gibco) and 0.5 mM 3-
isobutyl-1-methylxanthine (IBMX)). After 1 h, CL316,243 or forskolin
was added for 30 min. Following this, mediumwas aspirated and cells
were lysed directly in the wells by addition of 75% ethanol. The cells
were scraped off the wells and transferred to microcentrifuge tubes
on ice. Ethanol was removed by SpeedVac centrifugation and pellets
were suspended in 50 μl 4xTE buffer and sonicated for 5 s. After
centrifugation, a 25 μl aliquot was used for determination of cAMP
levels with the cyclic AMP assay system (GE Healthcare) according to
the manufacturer's instructions.
2.5. Chemicals
Collagenase (type II), EGF, forskolin, IBMX, LPA (oleoyl-L-α-
lysophosphatidic acid, sodium salt), PDGF and CL316,243 were
obtained from Sigma.
Collagenase and CL316,243 were dissolved in water, and LPA was
dissolved in 0.1% (w/v) fatty-acid free bovine serum albumin in
phosphate-buffered saline (PBS) (pH 7.2). PDGF was dissolved in
10 mMacetic acid, and EGFwas dissolved in serum-free culturemedia.
Forskolin and IBMX were dissolved in dimethyl sulfoxide (DMSO).
2.6. Statistical analysis
All data are presented as means±SEM. For the graphs and
statistical analysis, GraphPad Prism was used. For the curve-ﬁtting,
nonlinear regression, sigmoidal dose–response with ﬁxed Hill
coefﬁcient (=1) (in prism “log(agonist) vs. response”) was used.
This was applied for both the average concentration-response curve
and for each experiment to calculate basal level, delta response (basal
level subtracted from maximal response) and logEC50.The statistical
analysis was either performed by Student's t-test or a 2-way ANOVA.
In some instances a Bonferroni post test was used; this is indicated in
the ﬁgure legends; *pb0.05, **pb0.01, ***pb0.001, and ns pN0.05.
3. Results
To investigate how Cav1 affects the differentiation and signaling in
brown adipocytes, primary cultures from Cav1-ablated mice and
wild-type mice were grown to a pre-adipocyte state or to a mature
state. We investigated the state of differentiation, the response to a
β3-adrenergic receptor agonist (CL316,243) and the response to the
proliferative agents lysophosphatidic acid (LPA), platelet-derived
growth factor (PDGF) and epidermal growth factor (EGF).
3.1. Cav1(−/−) primary cultures accumulate lipid droplets and express
aP2 protein
As expected [21], Cav1 was expressed and visible by immunoﬂuo-
rescence microscopy in wild-type brown adipocytes (Fig. 1A, C). In the
brown adipocytes from Cav1-ablated mice, Cav1 was neither visible by
immunoﬂuorescence microscopy nor by immunoblotting (Fig. 1B, C).
Fig. 1. Characteristics of Cav1(−/−) primary brown adipocyte cultures. (A, B) Mature (day 8) wild-type and Cav1(−/−) brown adipocyte cultures were stained with bodipy
(green), Cav1 antibody (red) and Hoechst (blue) as described in Materials and methods. (C) The presence of Cav1 was investigated in mature wild-type and Cav1(−/−) cultures by
immunoblotting. (D) The presence of aP2 was investigated in mature wild-type and Cav1(−/−) cultures by immunoblotting. Data are presented as mean±SEM, Student's t-test
(p=0.2). Wild-type levels from each of 4 experiments were set to a 100%. Total Erk1/2 was used as loading control (no difference, data not shown).
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to accumulate lipids as seen by the lipid stain bodipy (Fig. 1A, B). As
expected [22], the adipocyte marker aP2 (FABP4) was expressed in
the wild-type cultures (Fig. 1D). aP2 was also expressed in the Cav1
(−/−) cultures, to the same extent as in the wild-type cultures,
principally in agreementwith Cohen et al. [12]. Themorphology of the
cell cultures was investigated by light microscopy. No difference could
be seen between the wild-type and Cav1(−/−) brown adipocytes,
with cells having the same shape and also containing multilocular
lipid droplets (not shown). This is in agreement with the appearance
of the tissue in vivo [12].
Thus, Cav1 did not seem to be essential for differentiation or the
ability to accumulate lipids in brown adipocytes.
3.2. β3-Adrenergic receptor- and forskolin-induced cAMP levels are
reduced in Cav1(−/−) primary brown adipocytes
Brown adipose tissue generates heat by nonshivering thermogen-
esis. This function is activated through the sympathetic nervous
system by release of norepinephrine. Norepinephrine binds andactivates adrenergic receptors, in particular the β3-adrenergic
receptors, and induces lipolysis through a cAMP-dependent pathway
[23]. In other cells and tissues, the β3-adrenergic receptors have been
shown to colocalize or cofractionate with caveolin [19,24], and in the
Cav1-ablated mice, β3-adrenergic receptor function in adipose tissue
is impaired [11,13,19]. To investigate whether the impairment is a cell
autonomous effect, i.e. whether the signaling pathway to cAMP was
changed in Cav1(−/−) brown adipocytes, cell cultures were
stimulated with the β3-adrenergic receptor agonist CL316,423 (CL).
As seen, CL was able to increase cAMP levels in a concentration-
response dependent manner both for the wild-type, as do other β3-
adrenergic receptor ligands [25], and for the Cav1(−/−) brown
adipocytes (Fig. 2A). However, the Cav1(−/−) cells had a lower
maximal response (Fig. 2A), with a signiﬁcantly lower delta value
(basal subtracted from maximal response, Table 1). Thus, the
response to CL was impaired. There was a tendency to a lower basal
level in the Cav1(−/−) brown adipocytes (p=0.06). This was most
probably not due to there being fewer cells, since all experiments for
immunoblotting indicated there was no difference in cell number
(Figs. 3 and 4A, B), and also not due to less differentiated cells, since
Fig. 2. Adrenergic cAMP response in mature brown adipocytes. (A) Concentration–
response curve of cAMP levels after treatment with CL316,243. The wild-type response
at 1 μMwas set to 100% for each of 9 experiments. Themeanwild-type response at 1 μM
corresponds to 5574 pmol cAMP in the well. 2-way ANOVA between the curves:
genotype ***, CL316,243 concentration *** and interaction *. (B) cAMP response to
10 μM forskolin. Data are normalized to the wild-type response in each of the
8 experiments. The mean wild-type response with forskolin corresponds to
16120 pmol cAMP in the well. (C) Concentration–response curve of cAMP levels after
treatment with CL316,243 normalized to the forskolin response (10 μM) of both wild-
type and Cav1(−/−) cultures (n=8). Values are based on the same data as in panels A
and B. Two-way ANOVA between the curves: genotype **, CL316,243 concentration ***
and interaction ns. (A–C) All data are presented as means±SEM. See also Table 1.
Table 1
Basal, delta response and log EC50 of CL316,243-induced cAMP level.
CL-induced cAMP levels
(% of wild-type 1 μM CL)
CL-induced cAMP levels
(% 10 μM forskolin in each
genotype)
Basal Δ Response logEC50 Basal Δ Response logEC50
Wild-type 14±2 92±6 −8.4±0.2 4±1 28±3 −8.4±0.2
Cav1(−/−) 8±2 42±15** −8.5±0.2 4±1 20±5 −8.5±0.2
For each experiment, the sigmoidal dose–response with ﬁxed Hill coefﬁcient (=1) was
analyzed in GraphPad Prism. The basal level, delta response and log EC50 were
compared between the wild-type and Cav1(−/−) brown adipocyte cultures. Both the
data per percent of wild-type 1 μM CL316,243 (n=9) and the percent of each forskolin
(n=8) are presented. Values are mean±SEM.
Fig. 3. LPA receptor response in pre-adipocytes. Concentration–response curve of Erk1/
2 phosphorylation levels after treatment with LPA. Data are presented as means±SEM
(n=4) and are normalized to the wild-type response at 100 μM. Two-way ANOVA
between the curves: genotype ns, LPA concentration *** and interaction ns. See also
Table 2.
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difference between the EC50 values for the wild-type and Cav1(−/−)
cells, indicating no desensitization of the receptors. This is in apparent
contrast to our study in Cav1-ablated mice, where a higher dose of
norepinephrine than the standard dose was able to rescue norepi-
nephrine-induced thermogenesis [13]. However, oxygen consump-
tion in isolated mature brown adipocytes reaches maximum level at
only a fraction of maximal cyclic AMP [26,27]. Thus, in the left
(unsaturated) part of the concentration-response curve, there will be
an apparent desensitization, i.e. here a higher stimulation can
compensate for the lower maximal capacity.In brown adipocytes, cAMP is produced by the β3-AR/Gs/adenylyl
cyclase pathway [23]. Adenylyl cyclase can colocalize with caveolin,
and the involvement of caveolin may affect cAMP production [28–31].
To investigate whether there was an impairment of the adenylyl
cyclase production of cAMP in cultured brown adipocytes, the
adenylyl cyclase agonist forskolin was used. Cav1-ablated cells were
not able to produce as much cAMP as did the wild-type cells,
indicating that adenylyl cyclase function was inhibited. Thus, Cav1 is
of importance for the adenylyl cyclase-mediated formation of cAMP.
To investigate whether the reduction in cAMP following CL-
stimulation could be fully explained by the reduced adenylyl cyclase
activity, we normalized the response of CL for each culture to the
forskolin response for each culture. As seen in Fig. 2C, the Cav1(−/−)
cultures still had a lower delta response, and a 2-way ANOVA between
the curves showed a signiﬁcant effect of genotype. There was no
difference in the basal levels or the EC50 (Table 1). Thus, Cav1 is
required both for the β3-adrenergic receptor-induced cAMP levels and
the adenylyl cyclase activity in the Cav1(−/−) brown adipocytes.3.3. Neither LPA-, PDGF- nor EGF-stimulated Erk1/2 phosphorylation is
changed in Cav1(−/−) brown pre-adipocytes
Proliferation agents such as lysophosphatidic acid (LPA), platelet-
derived growth factor (PDGF) and epidermal growth factor (EGF)
induce Erk1/2 phosphorylation in primary brown pre-adipocytes
[14,15]. Of these, LPA signaling is mediated via G-protein coupled
receptors (similarly to the β3-adrenergic receptor studied above),
whereas both PDGF and EGF receptors are receptor tyrosine kinases.
To investigate whether the signaling to Erk1/2 phosphorylation was
Fig. 4. PDGF and EGF receptor response in pre-adipocytes. (A) Concentration–response
curve of Erk1/2 phosphorylation after treatment with PDGF. Two-way ANOVA between
the curves: genotype ns, PDGF concentration *** and interaction ns. (B) Concentration–
response curve of Erk1/2 phosphorylation after treatment with EGF. Two-way ANOVA
between the curves: genotype ns, EGF concentration *** and interaction ns. (A, B) All
data are presented as means±SEM and are normalized to wild-type response at 10 ng/
ml in each experiment (PDGF n=4 and EGF n=5). See also Table 3.
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corresponding agonists and concentration-response curves were
compared between the Cav1(−/−) and wild-type cultures. Previous
investigations by other groups have yielded conﬂicting results about
the involvement of Cav1/caveolae and lipid rafts in LPA, EGF and
PDGF signaling [2,3,17,18,32–39].
In brown pre-adipocytes, LPA increased the Erk1/2 phosphoryla-
tion in the wild-type cells, as expected [15] (Fig. 3). LPA stimulation of
the Cav1(−/−) cells also increased Erk1/2 phosphorylation in a
concentration-dependent manner and to the same extent as in the
wild-type cultures (Fig. 3), and there was no difference in the basal
level, delta response or EC50 values (Table 2). Thus, even though the
LPA receptor is G protein coupled just as is the β3-adrenergic receptor,
Cav1 was not of importance for LPA-induced Erk1/2 phosphorylation
in brown pre-adipocytes.Table 2
Basal level, delta response and log EC50 of LPA-induced Erk1/2 phosphorylation.
LPA-induced Erk1/2 phosphorylation
Basal Δ Response logEC50
Wild-type 49±4 61±14 -6.7±0.2
Cav1(−/−) 39±5 72±5 -6.5±0.5
For each experiment (n=4), the sigmoidal dose–response with ﬁxed Hill coefﬁcient
(=1) was analyzed in GraphPad Prism. The basal level, delta response and log EC50
were compared between the wild-type and Cav1(−/−) brown adipocyte cultures.
Values are % of the 100 μM wild-type response and presented as mean±SEM.As expected [14], both PDGF and EGF increased the Erk1/2
phosphorylation in a concentration-dependent manner in the wild-
type cells (Fig. 4A). Similarly, in the Cav1(−/−) cells, both PDGF
and EGF stimulation increased Erk1/2 phosphorylation in a
concentration-dependent manner and to the same extent as in
the wild-type cultures (Fig. 4A). There were no differences in the
basal level, delta response or EC50 values (Table 3). Thus, Cav1 was
not of importance for either PDGF- or EGF-induced Erk1/2
phosphorylation in brown pre-adipocytes.
4. Discussion
In the present study, we investigated the importance of
caveolin-1 (Cav1) for differentiation and signaling in brown pre-
adipocytes and in mature brown adipocytes. We found that Cav1
(−/−) brown adipocytes were able to accumulate lipids and that
they expressed aP2 to the same extent as the wild-type adipocytes.
Lower cAMP response was observed as a result of both β3-
adrenergic receptor activation and adenylyl cyclase stimulation in
mature Cav1(−/−) cultures. However, Erk1/2 activation induced
by LPA, PDGF or EGF was not affected in the Cav1(−/−) pre-
adipocyte cultures.
4.1. Signaling in brown pre-adipocytes
In the Cav1(−/−) brown pre-adipocyte cultures, LPA, PDGF and
EGF were able to induce Erk1/2 phosphorylation with very similar
concentration-response curves as in the wild-type cultures, indicating
that Cav1 was not of importance for these signaling pathways. Since
PDGF- and EGF-induced cell proliferation in brown pre-adipocytes is
dependent on Erk1/2 activation [14], it is probable that EGF- and
PDGF-induced proliferation in brown pre-adipocytes is not affected by
the ablation of Cav1.
4.1.1. LPA-induced Erk1/2 activation
Two earlier studies investigating the effect of caveolae/lipid rafts
on LPA-induced Erk1/2 signaling have used cholesterol-disturbing
agents (such as methyl-β-cyclodextrin (mβCD) and ﬁlipin). In COS-7
cells, treatment with mβCD decreased LPA-induced Erk1/2 phos-
phorylation [17]. In pCMVEC cells, LPA receptors colocalizedwith both
Cav1 and clathrin. In these cells, treatment with ﬁlipin or mβCD did
not affect LPA signaling to the pro-inﬂammatory genes cyclooxygen-
ase (COX)-2 and inducible nitric-oxide synthase (iNOS) mRNA [18].
Thus, in the COS-7 cells, caveolae/lipid rafts were found to be
important for signaling, while in the pCMVEC cells, this was not the
case, and although LPA-induced signaling can be affected in some cell
types by caveolae/lipid rafts, in brown pre-adipocytes, Cav1 seems
not to inﬂuence LPA-induced Erk1/2 signaling (Fig. 3).
4.1.2. PDGF-induced Erk1/2 activation
In rat primary mesengial cells, a dominant-negative caveolin-mutant
increased PDGF-induced Erk1/2 activation [32]. However, in airway
smooth muscle cells, Cav1 siRNA induced spontaneous Erk1/2 activationTable 3






Basal Δ Response logEC50 Basal Δ Response logEC50
Wild-type 20±8 90±11 −0.3±0.4 44±11 54±13 −1.6±0.4
Cav1(−/−) 24±11 87±26 −0.4±0.4 33±6 66±9 −2.2±0.1
For each experiment (PDGF n=4, EGF n=5), the data were analyzed as in Table 2.
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are in contrast to our results where Cav1-ablation did not have any effect
on thePDGF-inducedErk1/2activation inbrownpre-adipocytes (Fig. 4A).
In addition, no differences in the Erk1/2 phosphorylation under basal
conditions (without agonist stimulation) were observed.
4.1.3. EGF-induced Erk1/2 activation
Transfectionwith Cav1 siRNA in hepatic C9 cells did not affect EGF-
induced Erk1/2 activation [38]. In contrast, transfection with Cav1
siRNA in mouse embryonic stem cells inhibited EGF-induced Erk1/2
activation [39]. Additionally, in a study by Park et al., the effect of age
on EGF-induced Erk1/2 activation in human diploid ﬁbroblasts was
investigated. They found that older cells, where EGF is not able to
induce Erk1/2 activation, had higher caveolin expression (all
subtypes) compared to young cells. By overexpressing Cav1 in
young cells, EGF-induced Erk1/2 phosphorylation was inhibited;
thus, caveolin had a negative role in the signaling [36]. As seen in
Fig. 4B, EGF-induced Erk1/2 activation in brown pre-adipocytes was
not affected by Cav1-ablation. The importance of caveolin for EGF-
induced Erk1/2 activation seems therefore to be cell-type speciﬁc and
dependent on the age of the cells.
4.2. Signaling in mature brown adipocytes
Both wild-type and Cav1(−/−) brown adipocytes were able to
differentiate into mature cells and to accumulate multilocular lipid
droplets and express aP2. In mature brown adipocytes, cAMP is
produced upon β3-adrenergic receptor-stimulation via Gs-protein and
adenylyl cyclase. The induction of cAMP levels leads to lipolysis and
nonshivering thermogenesis [23]. We found that in Cav1(−/−)
brown adipocytes, stimulation with CL316,243 (CL) or forskolin
resulted in lower cAMP levels compared to that in wild-type
adipocytes; thus, expression of caveolin has a positive effect on β3-
AR-induced cAMP levels and adenylyl cyclase activity. In contrast, in
C6 glioma cells transfected with Cav1 siRNA, isoprenaline (agonist on
all β-AR) induced higher levels of cAMP than it did in the control cells.
Also, forskolin-induced adenylyl cyclase activity and cAMP levels
were increased by transfection of Cav1 siRNA, and in Cav1-ablated
mouse striatum, forskolin-induced adenylyl cyclase activity was
higher than in the wild-type mouse [31]. Thus, in these systems,
caveolin had a suppressive role in β-AR signaling and adenylyl cyclase
activity. In agreement with this, caveolin peptides could inhibit
forskolin-induced cAMP levels in mouse brain, lung and heart [28].
Therefore, in these studies, caveolin had a negative effect on β-AR-
and adenylyl cyclase-induced cAMP levels, while in the present study
on brown adipocytes, a positive role for caveolin on β-AR- and
adenylyl cyclase-induced cAMP levels was found.
cAMP levels are regulated both by adenylyl cyclase activity and by
the activity of phosphodiesterases (PDEs) that hydrolyze cAMP to
AMP. In 3T3-L1 cells transfected with Cav1 siRNA, CL-induced PDE3
activity was reduced compared to control cells. Also, in CL-stimulated
Cav1(−/−) epididymal fat pads, the PDE3 activity was reduced
compared to the wild-type fat pads [19]. Thus, in these systems,
caveolin had a negative effect on cAMP levels. In the present study, a
PDE inhibitor (IBMX) was used, and thus an effect on PDE activity by
Cav1-ablation in our cells could not affect the CL- and forskolin-
induced cAMP levels.
Downstream of cAMP, PKA is activated and further phosphorylates
hormone-sensitive lipase (HSL) and perilipin [23]. In 3T3-L1 cells
transfected with Cav1 siRNA, CL-induced phosphorylation of HSL and
perilipin was reduced compared to control cells [19]. In agreement, in
Cav1(−/−) perigonadal fat pads, the CL-induced phosphorylation of
perilipin was less than that in wild-type fat pads. In wild-type fat pads,
CL induced the formation of a complex between perilipin, Cav1 and
cPKA (the catalytic subunit of PKA); this complexwas not present in the
Cav1(−/−) fat pads [11]. Thus, the decrease in lipolysis/thermogenesisseen in Cav1-ablated mice [11,13] may not only due to a decrease in
cAMP levels but also to an absence of the perilipin/Cav1/cPKA complex.
The ability to overcome the reduced thermogenesis by using a higher
degree of adrenergic stimulation [13] indicates, however, that the
formation of this complex is not essential.
Therefore, ablation of Cav1 seems to affect the mediators of
lipolysis in both white and brown adipocytes. In brown adipocytes,
caveolin-1 has a positive role for β3-AR-induced cAMP levels. In
adipose tissue, Cav1 is highly expressed and there are numerous
caveolae [1,2]. Itmay be natural to assume that the caveolae aremainly
involved in the transport functions related to lipolysis and fatty acid
export, but the present results indicate that they (or caveolin itself) at
least additionally are important for the signaling process leading to
lipolysis and thermogenesis.
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